CRI-report Romania Pharmaceutical Report - Eileen Gu

Send Message

I have been working in market/Industry research for almost 5 years since I got my Master's Degree of Management. I used to be an analyst for 3 years and turned to customer oriented position in recent years. I hope we can build a knowledge sharing networks to exchange information and values.... More

My company:: China Research and Intelligence
My blog:: Marketinfoguide

CRI-report Romania Pharmaceutical Report 0 comments

Jun 6, 2012 12:58 AM

Pharmaceutical sales at distribution prices increased by 16% y/y to RON 11.3bn (EUR 2.7bn) in the 12 months ending Mar 2012. Rx sales in pharmacies advanced by 11.1% y/y to RON 8.2bn, while sales of OTC drugs in pharmacies increased by 21.6% y/y to RON 11.6bn, indicating that purchase power started to pick up from the 2009-2010 level.
Pharmaceutical chains continued expansion by acquisitions in Q1 and there is still enough room for further M&A activity on the market, as the top 5 chains account for approximately 15% of the market. Pharmacy chain Sensiblu, part of A&D Pharma group, tops the market, with 374 pharmacies at end-May, followed by Catena and Dona chains. The number of pharmacies and drug stores increased by 8% y/y to a total of 7,259 in 2011, according to latest official statistics.
Full Report:http://www.cri-report.com/pharma-healthcare/1965-intellinews-romania-pharmaceutical-report-may-2012.html

Themes: pharmaceutical, sales, monthly, price, distribution, purchase power

Back To Eileen Gu's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.